UNION therapeutics A/S: Financial statements 2019
CVR: 33963750
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
UNION therapeutics A/S (CVR 33963750) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 11,649,000 and a net result of DKK -12,862,000 compared with USD -7,798,346 the year before. The profit margin was -110.4%. Equity in the 2019 report amounted to DKK -38,308,000,000.
- Revenue
- DKK 11,649,000
- Profit/Loss
- DKK -12,862,000
- Equity
- DKK -38,308,000,000
- Total Assets
- DKK 52,293,000,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 11.6M | - | -12.9M | -38.3B | - |
| 2018 | 0 USD | - | -7.8M USD | -5.3M USD | - |
| 2017 | 315K USD | - | -5.4M USD | 1.9M USD | - |
| 2016 | 729K USD | -343K USD | -485K USD | -195K USD | - |
| 2015 | 691K USD | -154K USD | -224K USD | -71K USD | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
UNION therapeutics A/S has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -7,798,346.
As of May 31, 2019, Andrew John Oakley has joined the board of directors of UNION therapeutics A/S.
About UNION therapeutics A/S
UNION therapeutics A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AntibioTx A/S and ANTIBIOTX ApS. The management consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. The board consists of Stig Løkke Pedersen (chair), Andrew John Oakley, Morten Otto Alexander Sommer and Peter Kristensen. The company's owners include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -11,802,644 and a net result of DKK -32,142,051 compared with DKK -98,922,000 the year before. Equity in the 2025 report amounted to DKK -147,650,138.